Bioservo has completed a directed issue of approximately SEK 36 million
NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR TO THE UNITED STATES, CANADA, JAPAN, SOUTH AFRICA, AUSTRALIA OR ANY OTHER JURISDICTION, WHERE SUCH ACTIONS ARE SUBJECT TO LEGAL RESTRICTIONS. THIS PRESS RELEASE DOES NOT MAKE AN OFFER REGARDING ANY SECURITIES IN BIOSERVO.Bioservo Technologies Aktiebolag (”Bioservo” or the ”Company”) has, in accordance with the Company’s press release earlier today and based on the authorization from the Annual General Meeting on April 19, 2021, resolved on a directed issue of 3,159,664 shares at a subscription price of SEK 11.50 per